327 related articles for article (PubMed ID: 7605896)
1. Cardiac hypertrophy induced by alpha- and beta-adrenergic receptor stimulation.
Zimmer HG; Kolbeck-Ruhmkorff C; Zierhut W
Cardioscience; 1995 Mar; 6(1):47-57. PubMed ID: 7605896
[TBL] [Abstract][Full Text] [Related]
2. The functional and metabolic responses of the heart to catecholamines are attenuated in diabetic rats.
Irlbeck M; Zimmer HG
Cardioscience; 1995 Jun; 6(2):131-8. PubMed ID: 7578910
[TBL] [Abstract][Full Text] [Related]
3. Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression.
Zimmer HG
J Mol Med (Berl); 1997; 75(11-12):849-59. PubMed ID: 9428617
[TBL] [Abstract][Full Text] [Related]
4. Different response of the rat left and right heart to norepinephrine.
Irlbeck M; Muhling O; Iwai T; Zimmer HG
Cardiovasc Res; 1996 Jan; 31(1):157-62. PubMed ID: 8849601
[TBL] [Abstract][Full Text] [Related]
5. Correlation between function and proto-oncogene expression in isolated working rat hearts under various overload conditions.
Horban A; Kolbeck-Rühmkorff C; Zimmer HG
J Mol Cell Cardiol; 1997 Nov; 29(11):2903-14. PubMed ID: 9405165
[TBL] [Abstract][Full Text] [Related]
6. In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol.
Hayes JS; Pollock GD; Fuller RW
J Pharmacol Exp Ther; 1984 Dec; 231(3):633-9. PubMed ID: 6094797
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II receptor blockade on hypoxia-induced right ventricular hypertrophy in rats.
Irlbeck M; Iwai T; Lerner T; Zimmer HG
J Mol Cell Cardiol; 1997 Nov; 29(11):2931-9. PubMed ID: 9405168
[TBL] [Abstract][Full Text] [Related]
8. Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy.
Zierhut W; Zimmer HG
Circ Res; 1989 Nov; 65(5):1417-25. PubMed ID: 2572358
[TBL] [Abstract][Full Text] [Related]
9. Selective desensitization of cardiac beta adrenoceptors by prolonged in vivo infusion of catecholamines in rats.
Chang HY; Klein RM; Kunos G
J Pharmacol Exp Ther; 1982 Jun; 221(3):784-9. PubMed ID: 6283064
[TBL] [Abstract][Full Text] [Related]
10. Effects of norepinephrine on the oxidative pentose phosphate pathway in the rat heart.
Zimmer HG; Lankat-Buttgereit B; Kolbeck-Rühmkorff C; Nagano T; Zierhut W
Circ Res; 1992 Aug; 71(2):451-9. PubMed ID: 1378361
[TBL] [Abstract][Full Text] [Related]
11. Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen.
Barth W; Deten A; Bauer M; Reinohs M; Leicht M; Zimmer HG
J Mol Cell Cardiol; 2000 Feb; 32(2):273-84. PubMed ID: 10722803
[TBL] [Abstract][Full Text] [Related]
12. Response of the rat heart to catecholamines and thyroid hormones.
Zimmer HG; Irlbeck M; Kolbeck-Rühmkorff CK
Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):105-14. PubMed ID: 7494538
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
[TBL] [Abstract][Full Text] [Related]
15. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
[TBL] [Abstract][Full Text] [Related]
17. Modulation of adrenergic receptors during regression of cardiac hypertrophy.
Matsui H; Makino N; Yano K; Nakanishi H; Hata T; Yanaga T
J Hypertens; 1994 Dec; 12(12):1353-7. PubMed ID: 7706693
[TBL] [Abstract][Full Text] [Related]
18. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic pathways and left ventricular remodeling.
Dorn GW
J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
[TBL] [Abstract][Full Text] [Related]
20. Changes in cardiac signal transduction systems in chronic ethanol treatment preceding the development of alcoholic cardiomyopathy.
Strasser RH; Nüchter I; Rauch B; Marquetant R; Seitz H
Herz; 1996 Aug; 21(4):232-40. PubMed ID: 8805003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
